LATEST

We will be proud to support researchers and companies

OUR SUPPORT in fighting COVID-19

After COVID-19 outbreak, rapid action is needed to develop solutions for testing a pathogen never seen before.

As a life science company, Cyanagen wants to offer its contribution in response to COVID-19, providing for its extensive portfolio of chemiluminescence and fluorescent detection reagents that could be useful in the development of several diagnostic solutions.

We will be proud to help researchers and companies around the world to support their efforts in fighting this outbreak.

The brightest ECL substrate ever seen on the market

WESTAR HYPERNOVA

Its extreme sensitivity and extraordinary light output allow the detection of trace amounts of proteins. The formulation provides a low background for an extremely high signal to noise ratio.

HIGHSENSER

SVILUPPO DI SISTEMI AD ALTA SENSIBILITA’ PER LA RILEVAZIONE DI BIOMARCATORI

Il progetto HIGHSENSER ha l’obiettivo di migliorare la sensibilità degli attuali sistemi per la rilevazione di biomarcatori con significato diagnostico, anche in campo oncologico. Grazie al contributo POR FESR 2014- 2020, Asse 1 Azione 1.1.2 “Servizi innovativi per le PMI”, Cyanagen si è avvalsa della consulenza di Centri di ricerca ed Università ad elevato livello […]
^